Coherus Oncology announced it will webcast presentations at the Guggenheim Healthcare Innovation Conference in Boston on November 10, 2026, and the Jefferies Global Healthcare Conference in London on November 16, 2026. These events will showcase the company's latest developments, including its approved PD-1 inhibitor LOQTORZI and pipeline candidates targeting various cancers. Investors can access the presentations online and request one-on-one meetings through their bank representatives. This participation highlights Coherus' efforts to advance its oncology pipeline and engage with the investment community.
Coherus Oncology's upcoming investor conferences provide context for healthcare sector activity on Pluang. For readers following healthcare stocks, here is Pluang's market snapshot as of Oct 27, 2026 19:51 WIB: Out of 150 priced US health-sector stocks, 75 rose and 69 fell. Notable movers include Illumina, Inc. (ILMN) at USD 275.39 with a 1.60% increase and 10X Genomics Inc (TXG) at USD 74.10 with a 1.56% rise, though TXG saw 95% sell order activity and a typical hold time of 92 days on Pluang.
Black Ore introduced Black Ore for Small Firms, an AI-powered tax automation platform designed for small to mid-sized accounting practices. It integrates with Intuit tax software, enabling firms to handle more clients without increasing staff by auto...
Alm. Brand A/S executed a share buy-back program from October 20 to 26, 2026, purchasing 1.81 million shares at an average price of DKK 17.41 each. This brings the total shares bought under the program to nearly 19.58 million, costing about DKK 324 m...
Hyphenate, an autonomous finance platform, secured $45 million in Series A funding following an 86-fold revenue increase and an 11-fold growth in customers over 12 months. Its AI-driven agents now handle 90% of routine finance work, such as invoicing...
CareCloud has named Mitchell Brie as Chief Compliance Officer to lead its growing healthcare compliance business. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud), will oversee corporate compliance and continue as Pre...
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
